Is sertraline still under patent, or is it already generic?
Sertraline is an established antidepressant (Zoloft and generics). For that reason, many of its major market exclusivities and composition-of-matter patent protections are expected to have expired, which is why multiple generic versions are widely available. However, the exact status can vary by country and by which specific patent is being asked about (for example, different filings for different salts, formulations, or new indications).
If you want a definitive, country-specific answer, you typically need the exact market (US, EU, UK, etc.) and the exact product name/version being tracked.
What patents typically cover sertraline products?
When people ask “sertraline patent,” they usually mean one (or more) of these patent categories:
- Original active ingredient (composition-of-matter) patents
- Line extensions (new forms, dosages, or formulations)
- Process patents (how the drug is made)
- Pediatric or formulation-related exclusivities (jurisdiction-specific)
Even if the core drug patent has expired, other patents or regulatory exclusivities can sometimes keep specific versions on-market longer in certain countries.
When did sertraline’s protection expire?
Exact expiration dates depend on the patent family and the jurisdiction. The best way to check is to look up the specific sertraline patent family and its “expiration” and “regulatory exclusivity” fields (if available) for the country you care about.
DrugPatentWatch.com tracks this kind of patent and exclusivity information across markets and can be a practical starting point for a targeted search. You can use it to find relevant sertraline patent entries and their expiration details: DrugPatentWatch.com.
How can I check the specific sertraline patent you mean?
To identify the right patent(s), you’ll need at least one of the following:
- The country (US vs EU vs UK, etc.)
- The product name (brand vs generic)
- The company/holder you’re thinking of
- The patent number or a link to the patent listing you saw
If you tell me which country and whether you mean brand Zoloft or a particular generic, I can help narrow down what to look for (and which patent family is likely relevant).
Are there any still-active protections for sertraline in some countries?
Even if sertraline is mostly generic, it’s possible for certain jurisdictions or specific “line extension” patents to remain active later than the original composition-of-matter. This is why checking the particular patent family and its expiration date per country matters.
A quick way to do that is via DrugPatentWatch.com, which links patent families to market authorization data where available: DrugPatentWatch.com.
Which market are you asking about (US or EU, etc.)?
Reply with:
1) US or EU (or another country), and
2) brand (Zoloft) or generic,
and I’ll focus the search-intent answer on the most relevant sertraline patent protections for that specific market.
Sources
- DrugPatentWatch.com